Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis

The mTOR inhibitor rapamycin ameliorates the clinical and biochemical phenotype of mouse, worm, and cellular models of mitochondrial disease, via an unclear mechanism. Here, we show that prolonged rapamycin treatment improved motor endurance, corrected morphological abnormalities of muscle, and incr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:EMBO Mol Med
Asıl Yazarlar: Civiletto, Gabriele, Dogan, Sukru Anil, Cerutti, Raffaele, Fagiolari, Gigliola, Moggio, Maurizio, Lamperti, Costanza, Benincá, Cristiane, Viscomi, Carlo, Zeviani, Massimo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220341/
https://ncbi.nlm.nih.gov/pubmed/30309855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201708799
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller